Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cerebral cancer suppressing phycocyanin-polylactic acid-adriamycin micelle and preparation method and application thereof

A technology of phycocyanin and doxorubicin, applied in the field of medical materials, can solve problems such as the inability to overcome the blood-brain barrier, and achieve the effects of improving stability and reducing cytotoxicity

Active Publication Date: 2016-04-13
SOUTH CHINA NORMAL UNIVERSITY
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, none of these drugs can overcome the problem of the blood-brain barrier and be used in the treatment of brain cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cerebral cancer suppressing phycocyanin-polylactic acid-adriamycin micelle and preparation method and application thereof
  • Cerebral cancer suppressing phycocyanin-polylactic acid-adriamycin micelle and preparation method and application thereof
  • Cerebral cancer suppressing phycocyanin-polylactic acid-adriamycin micelle and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] Example 1 Phycocyanin-polylactic acid micelles (PC-PLEL micelles) self-assembly synthesis

[0062] 1. Preparation method

[0063] (1) Accurately weigh 0.2g of phycocyanin powder, dissolve it into a 5mg / mL phycocyanin solution with 10ml of PBS (pH=7.4), stir for 30min, add 0.184g of polylactic acid copolymer (pla3600-peg2000) dissolved in 7.36ml of DMSO -pla3600) into a 25mg / ml solution and stirred at room temperature for 12 hours.

[0064] (2) Take 2ml of the solution and dialyze in ultrapure water for 24 hours with a suspension dialysis bag. During this period, change the water every 6 hours to ensure that all the residues of the reaction are removed. The bag was dialyzed in ultrapure water for 24 hours, and the water was changed every 6 hours during the period. After the dialysis, the solution was placed in the refrigerator for standby, and it was named PC-PLEL.

[0065] 2. Fourier transform infrared spectroscopy detection

[0066] (1) Put the PC-DOX-PLEL and PC-...

Embodiment 2

[0069] Example 2 Preparation of phycocyanin-polylactic acid-doxorubicin micelles (PC-DOX-PLEL micelles)

[0070] Synthesis schematic diagram of PC-DOX-PLEL micelles provided by the present invention is as attached figure 2 As shown, the details are as follows:

[0071] 1. Preparation of PC-DOX-PLEL micelles

[0072] Accurately weigh 0.2g of phycocyanin powder, dissolve it into 5mg / mL phycocyanin solution with 10ml PBS (pH=7.4), stir well, then add 200μl of doxorubicin hydrochloride (1mg / ml), stir for 30min, then Add and dissolve 0.184g polylactic acid copolymer (pla3600-peg2000-pla3600) with 7.36ml DMSO to form a 25mg / ml solution, and stir at room temperature for 12 hours.

[0073] Take 2ml of the solution and dialyze in ultrapure water for 24 hours with a suspension dialysis bag. During this period, change the water every 6 hours to ensure that all the residues of the reaction are removed. Dialyze in pure water for 24 hours, and change the water every 6 hours during the...

Embodiment 3

[0095] The anticancer application of embodiment 3PC-DOX-PLEL micelles

[0096] 1. C6 cell culture

[0097] The C6 cell line was provided by the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences. After the cells were proliferated and cultured to 80% in the culture flask, they were seeded on a 24-well plate at a density of 16,000 / well, and cultured for 1-2 days for subsequent experiments. The cell culture conditions are: high-glucose DMEM medium containing 10% newborn calf serum, 37°C, 5.0% CO 2 .

[0098] 2. Trypan blue staining and cell counting

[0099] We chose the method of trypan blue staining and cell counting to preliminarily count the cell death rate after adding the drug, so as to preliminarily test the killing effect of phycocyanin-polylactic acid micelles on C6 brain cancer cells.

[0100] (1) Cultivate C6 cells to a normal state in a 24-well plate, so that the cells can fully adhere to the wall and grow. The experiment was divided into fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a cerebral cancer suppressing phycocyanin-polylactic acid-adriamycin micelle. Phycocyanin and PLA-PEG-PLA are utilized as raw materials, and a phycocyanin-polylactic acid no-load micelle is formed according to addition reaction of carboxyl and self-assembly principle based on hydrophilia and hydrophobicity. According to the self-assembly principle, adriamycin is coated in the no-load micelle to assemble by itself to form the micelle. The phycocyanin-polylactic acid-adriamycin micelle is a novel nano medicine capable of directly acting on tumor through blood-brain barrier to suppress cerebral cancer cells and capable of releasing slowly to retain in blood for a long time, thereby overcoming influence and limit of the blood-brain barrier to drug treatment effect. Besides, the micelle is prepared from natural or degradable components which are not involved with organic solvents during synthesis, has the advantages such as good biocompatibility, biodegradability, hypotoxicity, high loading capacity, and accordingly has high application potential in treating cerebral cancer.

Description

technical field [0001] The invention belongs to the technical field of medical materials. More specifically, it relates to a phycocyanin-polylactic acid-doxorubicin micelle for inhibiting brain cancer and its preparation method and application. Background technique [0002] Brain tumors refer to a heterogeneous population of primary and metastatic tumors of the central nervous system and are life-threatening diseases characterized by extremely low survival rates. According to statistics, the incidence of brain cancer is 40 / 100,000. In terms of the incidence of systemic tumors, brain tumors rank fifth (6.31%), only lower than stomach, uterus, breast, and esophagus tumors. Although the morbidity rate of the disease is not the highest, the fatality rate is very high. [0003] Current research shows that the treatment of malignant brain tumors includes surgical resection, radiotherapy, chemotherapy and combination therapy. These methods can greatly prolong the survival time o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/107A61K31/704A61K47/42A61P35/00
CPCA61K9/1075A61K31/704A61K47/42
Inventor 关燕清赵孟阳钟小飞
Owner SOUTH CHINA NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com